Blocking HCV Entry as Potential Antiviral Therapy
Published on: Monday 10 January 2022
G0212.10N and G052112N), the Belgian state (IUAP P6/36-HEPRO) and the EU (FP6, HEPACIVAC). The authors have no other relevant affiliations or financial involvement with any organization or entity ...
News source: https://www.medscape.com/viewarticle/766513_0
